Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
Eligible age
18–79 yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The objective of this clinical trial is to explore the effects of Salovum®, an egg yolk powder enriched with the endogenous protein antisecretory factor, and SPC® flakes , hydrothermically processed oats, on cerebral edema with clinical symptoms in participants with brain tumors. The primary questions the trial seeks to answer are: * Can Salovum® and SPC® flakes have effect on clinical symptoms of tumor-induced cerebral edema? * Can Salovum® and SPC® flakes induce regression of radiological edema in tumor-induced cerebral edema Additionally, the study will investigate the impact of Salovum® and SPC® flakes in steroid refractory, steroid naïve cerebral edema and type of barin tumor Researchers will: Evaluate edema change from baseline by MRI after 14 days Evaluate neurological and cognitive symptoms Register dose of steroid medications Participants will: * Ingest Salovum® 11g three times daily for 14 days, thereafter tapered during 14 days * Ingest SPC® flakes 1g/kg daily from day 7
Sponsor: Peter Siesjö
You may qualify if…
- ✓ 1. Age 18-79 years
- ✓ 2. Known or radiologically suspected primary or secondary brain tumor (suspected metastasis, meningioma, glioma, etc.) with surrounding edema causing clinical signs
- ✓ 3. GCS 14-15
- ✓ 4. WHO ECOG performance status 0-2
- ✓ 5. Planned or started cortisone treatment
- ✓ 6. Ability to provide informed consent
You may not qualify if…
- ✕ 1. Egg yolk allergy
- ✕ 2. Midline shift \>5mm
- ✕ 3. GCS ≤13
- ✕ 4. Epilepsy as sole symptom from the cerebral edema
Source: ClinicalTrials.gov · NCT06710249 · last updated 2025-01-27